Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEFFREY T RADO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1881706455
CMS profile
673513
Location
CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$64,210.69

68 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $26,652.32 23
Axsome Therapeutics, Inc. $19,918.95 25
Alkermes, Inc. $17,545.94 19
Boehringer Ingelheim Pharmaceuticals, Inc. $93.48 1

Page 2 of 2; records 51–68 of 68 matching records. This page contains 18 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEFFREY T RADO

NPI 1881706455 · CMS profile ID 673513

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

CHICAGO, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–68 of 68 matching records. This page contains 18 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1881706455?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEFFREY T RADO, NPI 1881706455, CMS profile ID 673513. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–68 of 68 matching records. This page contains 18 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1881706455?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JEFFREY T RADO, NPI 1881706455, CMS profile ID 673513. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–68 of 68 matching records. This page contains 18 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1881706455?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JEFFREY T RADO, NPI 1881706455, CMS profile ID 673513, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–68 of 68 matching records. This page contains 18 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1881706455?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

68 matching records · $64,210.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 68 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–68 of 68.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alkermes, Inc. $23.2704/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222618938 CMS
Alkermes, Inc. $60.0004/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222618940 CMS
Alkermes, Inc. $48.6604/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222618942 CMS
Alkermes, Inc. $75.0004/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222618944 CMS
Alkermes, Inc. $23.2704/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222618928 CMS
Alkermes, Inc. $125.0004/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222618930 CMS
Alkermes, Inc. $25.0004/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1222618932 CMS
Axsome Therapeutics, Inc. $8,775.0004/04/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1235756833 CMS
Axsome Therapeutics, Inc. $134.5803/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235786466 CMS
Axsome Therapeutics, Inc. $111.4703/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1235815151 CMS
Axsome Therapeutics, Inc. $20.0503/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235788054 CMS
Axsome Therapeutics, Inc. $34.2403/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235788060 CMS
Axsome Therapeutics, Inc. $49.4503/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235788062 CMS
Axsome Therapeutics, Inc. $74.1903/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235788064 CMS
Axsome Therapeutics, Inc. $24.7303/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235803212 CMS
Axsome Therapeutics, Inc. $24.7303/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235803214 CMS
Axsome Therapeutics, Inc. $303.9703/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1235815120 CMS
Axsome Therapeutics, Inc. $306.9703/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1235815187 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $29,169.21 30
PY2020 $8,620.82 8
PY2021 $24,147.50 21
PY2022 $22,853.86 30
PY2023 $23,809.54 26
PY2024 $35,110.25 47
PY2025 $64,210.69 68

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $233,432.00 37
PY2024 Recipient $2,200.00 1
PY2024 Principal investigator $101,465.84 37
PY2023 Principal investigator $109,578.16 14
PY2022 Principal investigator $99,196.65 17
PY2021 Principal investigator $129,116.51 28
PY2020 Principal investigator $161,984.21 69
PY2019 Principal investigator $174,521.59 110

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

37 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $2,116.00 12/25/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms No dispute reported 06/30/2026 1175359287
Principal investigator 1 Janssen Research & Development, LLC $7,660.00 12/05/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms No dispute reported 06/30/2026 1175359726
Principal investigator 1 ABBVIE INC. $6,643.56 11/07/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A 52-week, Phase 2, Open-label Trial to Evaluate the Long-term Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia No dispute reported 06/30/2026 1202523593
Principal investigator 1 Janssen Research & Development, LLC $3,406.00 10/30/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms No dispute reported 06/30/2026 1175359408
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $21,080.00 10/24/2025 Non-covered Recipient Entity
Northwestern University School Of Medicine
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia No dispute reported 06/30/2026 1235995159
Principal investigator 1 Janssen Research & Development, LLC $19,862.20 10/13/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms No dispute reported 06/30/2026 1175359279
Principal investigator 1 ABBVIE INC. $21,882.28 10/07/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A 52-week, Phase 2, Open-label Trial to Evaluate the Long-term Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia No dispute reported 06/30/2026 1202513481
Principal investigator 1 Janssen Research & Development, LLC $6,783.00 09/29/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175359484
Principal investigator 1 ABBVIE INC. $14,628.96 09/12/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A 52-week, Phase 2, Open-label Trial to Evaluate the Long-term Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia No dispute reported 06/30/2026 1202510850
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047129
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047131
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047189
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047191
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047199
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047201
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047203
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047205
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047207
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047209
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047211
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047213
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047215
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047217
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047219
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047221
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047223
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047225
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 05/14/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047227
Principal investigator 1 Janssen Research & Development, LLC $28,050.00 04/24/2025 Non-covered Recipient Entity
NORTHWESTERN UNIVERSITY
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175359414
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $82,346.00 03/07/2025 Non-covered Recipient Entity
Northwestern University School Of Medicine
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE) No dispute reported 06/30/2026 1235995157
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 02/12/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047185
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 02/12/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047187
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 01/22/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047181
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 01/22/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047183
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $739.00 01/22/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047193
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 01/22/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047195
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $709.00 01/22/2025 Non-covered Recipient Entity
Northwestern University
TV50717-CNS-40223 No dispute reported 06/30/2026 1244047197